Transcriptome-based network analysis reveals renal cell type-specific dysregulation of hypoxia-associated transcripts

Scientific Reports

Volumn 7, Issue 1, 2017, Pages

  Shved, Natallia ^a   Warsow, Gregor ^b,g   Eichinger, Felix ^c   Hoogewijs, David ^a,d   Brandt, Simone ^e   Wild, Peter ^e   Kretzler, Matthias ^c   Cohen, Clemens D ^a,f   Lindenmeyer, Maja T ^a,f  

^a UNIVERSITY OF ZURICH   (Switzerland)

^b UNIVERSITY MEDICINE GREIFSWALD   (Germany)

^c UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^d UNIVERSITY OF FRIBOURG   (Switzerland)

^e UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^f UNIVERSITY OF MUNICH   (Germany)

^g GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BASIC HELIX LOOP HELIX TRANSCRIPTION FACTOR; ENDOTHELIAL PAS DOMAIN-CONTAINING PROTEIN 1; HYPOXIA INDUCIBLE FACTOR 1ALPHA; TRANSCRIPTOME;

CELL CULTURE; CELL HYPOXIA; CELL LINE; CHRONIC KIDNEY FAILURE; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENE REGULATORY NETWORK; GENETICS; GLOMERULUS; HUMAN; HYPOXIA; KIDNEY; METABOLISM; PATHOLOGY; PODOCYTE;

BASIC HELIX-LOOP-HELIX TRANSCRIPTION FACTORS; CELL HYPOXIA; CELL LINE; CELLS, CULTURED; GENE EXPRESSION PROFILING; GENE ONTOLOGY; GENE REGULATORY NETWORKS; HUMANS; HYPOXIA; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; KIDNEY; KIDNEY GLOMERULUS; PODOCYTES; RENAL INSUFFICIENCY, CHRONIC; TRANSCRIPTOME;

EID: 85027878248     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/s41598-017-08492-y     Document Type: Article

References (65)

1. Covic, A. et al. Systematic review of the evidence underlying the association between mineral metabolism disturbances and risk of all-cause mortality, cardiovascular mortality and cardiovascular events in chronic kidney disease. Nephrol Dial Transplant 24, 1506-1523, doi:10.1093/ndt/gfn613 (2009).
2. USRDS. United States Renal Data System. 2016 USRDS annual data report: Epidemiology of kidney disease in the United States., http://www.usrds.org/atlas.aspx (2016).
3. Levey, A. S. & Coresh, J. Chronic kidney disease. Lancet 379, 165-180, doi:10.1016/S0140-6736(11)60178-5 (2012).
4. Theilig, F. Spread of glomerular to tubulointerstitial disease with a focus on proteinuria. Ann Anat 192, 125-132, doi:10.1016/j. aanat.2010.03.003 (2010).
5. Gilbert, R. E. & Cooper, M. E. The tubulointerstitium in progressive diabetic kidney disease: more than an aftermath of glomerular injury? Kidney international 56, 1627-1637, doi:10.1046/j.1523-1755.1999.00721.x (1999).
6. Fine, L. G. & Norman, J. T. Chronic hypoxia as a mechanism of progression of chronic kidney diseases: from hypothesis to novel therapeutics. Kidney international 74, 867-872, doi:10.1038/ki.2008.350 (2008).
7. Majmundar, A. J., Wong, W. J. & Simon, M. C. Hypoxia-inducible factors and the response to hypoxic stress. Molecular cell 40, 294-309, doi:10.1016/j.molcel.2010.09.022 (2010).
8. Rosenberger, C. et al. Expression of hypoxia-inducible factor-1alpha and -2alpha in hypoxic and ischemic rat kidneys. Journal of the American Society of Nephrology: JASN 13, 1721-1732 (2002).
9. Wiesener, M. S. et al. Widespread hypoxia-inducible expression of HIF-2alpha in distinct cell populations of different organs. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 17, 271-273, doi:10.1096/fj.02-0445fje (2003).
10. Fine, L. G., Orphanides, C. & Norman, J. T. Progressive renal disease: the chronic hypoxia hypothesis. Kidney Int Suppl 65, S74-78 (1998).
11. Manotham, K. et al. Transdifferentiation of cultured tubular cells induced by hypoxia. Kidney international 65, 871-880, doi:10.1111/j.1523-1755.2004.00461.x (2004).
12. Tanaka, T. et al. Hypoxia induces apoptosis in SV40-immortalized rat proximal tubular cells through the mitochondrial pathways, devoid of HIF1-mediated upregulation of Bax. Biochemical and biophysical research communications 309, 222-231 (2003).
13. Higgins, D. F. et al. Hypoxia promotes fibrogenesis in vivo via HIF-1 stimulation of epithelial-to-mesenchymal transition. The Journal of clinical investigation 117, 3810-3820, doi:10.1172/JCI30487 (2007).
14. Bernhardt, W. M. et al. Involvement of hypoxia-inducible transcription factors in polycystic kidney disease. The American journal of pathology 170, 830-842, doi:10.2353/ajpath.2007.060455 (2007).
15. Lindenmeyer, M. T. et al. Interstitial vascular rarefaction and reduced VEGF-A expression in human diabetic nephropathy. Journal of the American Society of Nephrology: JASN 18, 1765-1776, doi:10.1681/ASN.2006121304 (2007).
16. Neusser, M. A. et al. Human nephrosclerosis triggers a hypoxia-related glomerulopathy. The American journal of pathology 176, 594-607, doi:10.2353/ajpath.2010.090268 (2010).
17. Futrakul, N., Butthep, P., Laohareungpanya, N., Chaisuriya, P. & Ratanabanangkoon, K. A defective angiogenesis in chronic kidney disease. Renal failure 30, 215-217, doi:10.1080/08860220701813335 (2008).
18. Khatir, D. S., Pedersen, M., Jespersen, B. & Buus, N. H. Evaluation of Renal Blood Flow and Oxygenation in CKD Using Magnetic Resonance Imaging. Am J Kidney Dis 66, 402-411, doi:10.1053/j.ajkd.2014.11.022 (2015).
19. Neugarten, J. & Golestaneh, L. Blood oxygenation level-dependent MRI for assessment of renal oxygenation. International journal of nephrology and renovascular disease 7, 421-435, doi:10.2147/IJNRD.S42924 (2014).
20. Stiehl, D. P. et al. Non-canonical HIF-2alpha function drives autonomous breast cancer cell growth via an AREG-EGFR/ErbB4 autocrine loop. Oncogene 31, 2283-2297, doi:10.1038/onc.2011.417 (2012).
21. Wenger, R. H., Stiehl, D. P. & Camenisch, G. Integration of oxygen signaling at the consensus HRE. Science's STKE: signal transduction knowledge environment 2005, re12, doi:10.1126/stke.3062005re12 (2005).
22. Warsow, G. et al. PodNet, a protein-protein interaction network of the podocyte. Kidney international 84, 104-115, doi:10.1038/ki.2013.64 (2013).
23. Gunaratnam, L. & Bonventre, J. V. HIF in kidney disease and development. Journal of the American Society of Nephrology: JASN 20, 1877-1887, doi:10.1681/ASN.2008070804 (2009).
24. Nangaku, M. Chronic hypoxia and tubulointerstitial injury: a final common pathway to end-stage renal failure. Journal of the American Society of Nephrology: JASN 17, 17-25, doi:10.1681/ASN.2005070757 (2006).
25. Inoue, T. et al. Noninvasive evaluation of kidney hypoxia and fibrosis using magnetic resonance imaging. Journal of the American Society of Nephrology: JASN 22, 1429-1434, doi:10.1681/ASN.2010111143 (2011).
26. Yin, W. J. et al. Noninvasive evaluation of renal oxygenation in diabetic nephropathy by BOLD-MRI. European journal of radiology 81, 1426-1431, doi:10.1016/j.ejrad.2011.03.045 (2012).
27. Wang, Z. J., Kumar, R., Banerjee, S. & Hsu, C. Y. Blood oxygen level-dependent (BOLD) MRI of diabetic nephropathy: preliminary experience. Journal of magnetic resonance imaging: JMRI 33, 655-660, doi:10.1002/jmri.22501 (2011).
28. Epstein, F. H., Veves, A. & Prasad, P. V. Effect of diabetes on renal medullary oxygenation during water diuresis. Diabetes care 25, 575-578 (2002).
29. Michaely, H. J. et al. Renal BOLD-MRI does not reflect renal function in chronic kidney disease. Kidney international 81, 684-689, doi:10.1038/ki.2011.455 (2012).
30. Tanaka, T., Yamaguchi, J., Higashijima, Y. & Nangaku, M. Indoxyl sulfate signals for rapid mRNA stabilization of Cbp/p300-interacting transactivator with Glu/Asp-rich carboxy-terminal domain 2 (CITED2) and suppresses the expression of hypoxiainducible genes in experimental CKD and uremia. FASEB journal: official publication of the Federation of American Societies for Experimental Biology 27, 4059-4075, doi:10.1096/fj.13-231837 (2013).
31. Nallamshetty, S., Chan, S. Y. & Loscalzo, J. Hypoxia: a master regulator of microRNA biogenesis and activity. Free radical biology & medicine 64, 20-30, doi:10.1016/j.freeradbiomed.2013.05.022 (2013).
32. Xu, X. et al. miR-21 in ischemia/reperfusion injury: a double-edged sword? Physiological genomics 46, 789-797, doi:10.1152/physiolgenomics.00020.2014 (2014).
33. Lee, Y. M. et al. Determination of hypoxic region by hypoxia marker in developing mouse embryos in vivo: a possible signal for vessel development. Developmental dynamics: an official publication of the American Association of Anatomists 220, 175-186, doi: 10.1002/1097-0177(20010201)220:2<175::AID-DVDY1101>3.0.CO;2-F (2001).
34. Schley, G. et al. Hypoxia inhibits nephrogenesis through paracrine Vegfa despite the ability to enhance tubulogenesis. Kidney international. doi:10.1038/ki.2015.214 (2015).
35. Bush, K. T. et al. TGF-beta superfamily members modulate growth, branching, shaping, and patterning of the ureteric bud. Developmental biology 266, 285-298 (2004).
36. Wang, S. et al. Renal bone morphogenetic protein-7 protects against diabetic nephropathy. Journal of the American Society of Nephrology: JASN 17, 2504-2512, doi:10.1681/ASN.2006030278 (2006).
37. Zeisberg, M. & Kalluri, R. Reversal of experimental renal fibrosis by BMP7 provides insights into novel therapeutic strategies for chronic kidney disease. Pediatr Nephrol 23, 1395-1398, doi:10.1007/s00467-008-0818-x (2008).
38. Baumann, B., Hayashida, T., Liang, X. & Schnaper, H. W. Hypoxia-inducible factor-1alpha promotes glomerulosclerosis and regulates COL1A2 expression through interactions with Smad3. Kidney international 90, 797-808, doi:10.1016/j.kint.2016.05.026 (2016).
39. Kushida, N. et al. Hypoxia-Inducible Factor-1alpha Activates the Transforming Growth Factor-beta/SMAD3 Pathway in Kidney Tubular Epithelial Cells. American journal of nephrology 44, 276-285, doi:10.1159/000449323 (2016).
40. Barisoni, L., Kriz, W., Mundel, P. & D'Agati, V. The dysregulated podocyte phenotype: a novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. Journal of the American Society of Nephrology: JASN 10, 51-61 (1999).
41. Shkreli, M. et al. Reversible cell-cycle entry in adult kidney podocytes through regulated control of telomerase and Wnt signaling. Nature medicine 18, 111-119, doi:10.1038/nm.2550 (2012).
42. Lasagni, L., Lazzeri, E., Shankland, S. J., Anders, H. J. & Romagnani, P. Podocyte mitosis - a catastrophe. Current molecular medicine 13, 13-23 (2013).
43. Niranjan, T. et al. The Notch pathway in podocytes plays a role in the development of glomerular disease. Nature medicine 14, 290-298, doi:10.1038/nm1731 (2008).
44. Sharma, M. et al. Inhibition of Notch pathway attenuates the progression of human immunodeficiency virus-associated nephropathy. Am J Physiol Renal Physiol 304, F1127-1136, doi:10.1152/ajprenal.00475.2012 (2013).
45. Sainson, R. C. & Harris, A. L. Hypoxia-regulated differentiation: let's step it up a Notch. Trends in molecular medicine 12, 141-143, doi:10.1016/j.molmed.2006.02.001 (2006).
46. Fornoni, A., Merscher, S. & Kopp, J. B. Lipid biology of the podocyte-new perspectives offer new opportunities. Nature reviews. Nephrology 10, 379-388, doi:10.1038/nrneph.2014.87 (2014).
47. Merscher, S., Pedigo, C. E. & Mendez, A. J. Metabolism, energetics, and lipid biology in the podocyte-cellular cholesterol-mediated glomerular injury. Frontiers in endocrinology 5, 169, doi:10.3389/fendo.2014.00169 (2014).
48. Kim, B. S., Chen, J., Weinstein, T., Noiri, E. & Goligorsky, M. S. VEGF expression in hypoxia and hyperglycemia: reciprocal effect on branching angiogenesis in epithelial-endothelial co-cultures. Journal of the American Society of Nephrology: JASN 13, 2027-2036 (2002).
49. Kolev, V. et al. EGFR signalling as a negative regulator of Notch1 gene transcription and function in proliferating keratinocytes and cancer. Nature cell biology 10, 902-911, doi:10.1038/ncb1750 (2008).
50. Loboda, A., Jozkowicz, A. & Dulak, J. HIF-1 versus HIF-2-is one more important than the other? Vascular pharmacology 56, 245-251, doi:10.1016/j.vph.2012.02.006 (2012).
51. Hu, C. J., Sataur, A., Wang, L., Chen, H. & Simon, M. C. The N-terminal transactivation domain confers target gene specificity of hypoxia-inducible factors HIF-1alpha and HIF-2alpha. Molecular biology of the cell 18, 4528-4542, doi:10.1091/mbc.E06-05-0419 (2007).
52. Cohen, C. D., Frach, K., Schlondorff, D. & Kretzler, M. Quantitative gene expression analysis in renal biopsies: a novel protocol for a high-throughput multicenter application. Kidney international 61, 133-140, doi:10.1046/j.1523-1755.2002.00113.x (2002).
53. Martini, S. et al. Integrative biology identifies shared transcriptional networks in CKD. Journal of the American Society of Nephrology: JASN 25, 2559-2572, doi:10.1681/ASN.2013080906 (2014).
54. Cohen, C. D. et al. Comparative promoter analysis allows de novo identification of specialized cell junction-associated proteins. Proceedings of the National Academy of Sciences of the United States of America 103, 5682-5687, doi:10.1073/pnas.0511257103 (2006).
55. Johnson, W. E., Li, C. & Rabinovic, A. Adjusting batch effects in microarray expression data using empirical Bayes methods. Biostatistics 8, 118-127, doi:10.1093/biostatistics/kxj037 (2007).
56. Levey, A. S. et al. A new equation to estimate glomerular filtration rate. Ann Intern Med 150, 604-612 (2009).
57. Stiehl, D. P. et al. Increased prolyl 4-hydroxylase domain proteins compensate for decreased oxygen levels. Evidence for an autoregulatory oxygen-sensing system. The Journal of biological chemistry 281, 23482-23491, doi:10.1074/jbc.M601719200 (2006).
58. Tusher, V. G., Tibshirani, R. & Chu, G. Significance analysis of microarrays applied to the ionizing radiation response. Proceedings of the National Academy of Sciences of the United States of America 98, 5116-5121, doi:10.1073/pnas.091062498 (2001).
59. Lindenmeyer, M. T. et al. Proteinuria and hyperglycemia induce endoplasmic reticulum stress. Journal of the American Society of Nephrology: JASN 19, 2225-2236, doi:10.1681/ASN.2007121313 (2008).
60. Langfelder, P. & Horvath, S. WGCNA: an R package for weighted correlation network analysis. BMC bioinformatics 9, 559, doi:10.1186/1471-2105-9-559 (2008).
61. Maere, S., Heymans, K. & Kuiper, M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks. Bioinformatics 21, 3448-3449, doi:10.1093/bioinformatics/bti551 (2005).
62. Werner, T. et al. Elucidating functional context within microarray data by integrated transcription factor-focused gene-interaction and regulatory network analysis. European cytokine network 24, 75-90, doi:10.1684/ecn.2013.0336 (2013).
63. Shannon, P. et al. Cytoscape: a software environment for integrated models of biomolecular interaction networks. Genome research 13, 2498-2504, doi:10.1101/gr.1239303 (2003).
64. Sales, G., Calura, E. & Romualdi, C. graphite: GRAPH Interaction from pathway Topological Environment. R package version 1.20.1 (2016).
65. Berriz, G. F., King, O. D., Bryant, B., Sander, C. & Roth, F. P. Characterizing gene sets with Func Associate. Bioinformatics 19, 2502-2504 (2003).